Dr. Eric Matthew Stehly, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2535 Ira E Woods Ave, Grapevine, TX 76051 Phone: 817-481-2121 Fax: 817-488-4493 |
Dr. Michael Ryan Briseno, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2535 Ira E Woods Ave, Grapevine, TX 76051 Phone: 817-481-2121 Fax: 817-488-4493 |
Dr. Scott Wenger, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 815 Ira E Woods Ave, Ste 100, Grapevine, TX 76051 Phone: 817-421-0505 Fax: 817-421-6060 |
Dr. Amir M Khan, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 815 Ira E Woods Ave, Ste 100, Grapevine, TX 76051 Phone: 817-421-0505 Fax: 817-421-6060 |
Dr. Kristen Elizabeth Fleager, M.D. Orthopaedic Surgery - Hand Surgery Medicare: Accepting Medicare Assignments Practice Location: 2535 Ira E Woods Ave, Grapevine, TX 76051 Phone: 817-481-2121 Fax: 817-488-4493 |
Dr. Pat Andrew Peters, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2535 Ira E Woods Ave, Grapevine, TX 76051 Phone: 817-481-2121 Fax: 817-488-4493 |
Mr. Jeffrey Dean Moffett, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2535 Ira E Woods Ave, Grapevine, TX 76051 Phone: 817-481-2121 Fax: 817-488-4493 |
J. David Thompson, MD Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2020 W State Highway 114, Suite 110, Grapevine, TX 76051 Phone: 817-310-0810 Fax: 817-812-3525 |
Dr. Zubin G Khubchandani, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 815 Ira E Woods Ave, Ste 100, Grapevine, TX 76051 Phone: 817-421-0505 Fax: 817-421-6060 |
Dr. Ryan Patrick Mulligan, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2535 Ira E Woods Ave, Grapevine, TX 76051 Phone: 817-481-2121 Fax: 817-488-4493 |
Dr. Nathan Edward Williams Ii, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2535 Ira E Woods Ave, Grapevine, TX 76051 Phone: 817-481-2121 Fax: 817-488-4493 |
Dr. Theodore Thomas Peters, M.D. Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2535 Ira E Woods Avenue, Grapevine, TX 76051 Phone: 817-481-2121 Fax: 817-488-4493 |
Casey Robert Stuhlman, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2535 Ira E Woods Ave, Grapevine, TX 76051 Phone: 817-481-2121 Fax: 817-488-4493 |
Dr. Kerry Michael Donegan, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2535 Ira E Woods Ave, Grapevine, TX 76051 Phone: 817-481-2121 Fax: 817-488-4493 |
Dr. Roderick Marcus Capelo, M.D. Orthopaedic Surgery - Pediatric Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2020 W State Highway 114, Suite 110, Grapevine, TX 76051 Phone: 817-310-0810 Fax: 817-812-3525 |
News Archive
Individuals with diabetes appear to spend more days in the intensive care unit, use more ventilator support and have more complications during hospitalization for trauma than non-diabetics, according to a report in the July issue of Archives of Surgery.
Two studies, published together on bmj.com, add further weight to the theory that pre-eclampsia and cardiovascular diseases may share common causes or mechanisms.
Delcath Systems, Inc., a medical technology company testing its proprietary treatment system for primary and metastatic cancers to the liver, announced today that the American Society of Clinical Oncology (ASCO) has accepted an abstract for oral presentation of Delcath's Phase III Trial Data comparing percutaneous hepatic perfusion with melphalan (PHP-mel) to the best alternative care for patients with hepatic metastases from ocular or cutaneous melanoma for ASCO's 2010 Annual Meeting, to be held June 4-8, 2010 at McCormick Place in Chicago.
A multidisciplinary team led by Johns Hopkins researcher Venu Raman, Ph.D., with notable contributions from Guus Bol, Farhad Vesuna and Phuoc Tran of Johns Hopkins, has identified a new therapy for lung cancer, the most common cancer worldwide. The therapy has been in development for six years and involves a first-in-class molecule designed by the team.
› Verified 3 days ago